X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (112) 112
humans (72) 72
anti-thrombotic therapy (62) 62
animals (49) 49
male (40) 40
anti-thrombotic (30) 30
thrombosis (28) 28
rats (23) 23
female (22) 22
fibrinolytic agents - pharmacology (21) 21
fibrinolytic agents - therapeutic use (20) 20
pharmacology & pharmacy (20) 20
cardiac & cardiovascular systems (18) 18
chemistry, medicinal (18) 18
thrombosis - drug therapy (18) 18
anti-thrombotic activity (17) 17
hematology (17) 17
mice (17) 17
middle aged (17) 17
aspirin (16) 16
platelet aggregation inhibitors - therapeutic use (16) 16
blood platelets - drug effects (15) 15
atrial fibrillation (14) 14
prevention (14) 14
anticoagulants - therapeutic use (13) 13
platelet aggregation - drug effects (13) 13
risk factors (13) 13
treatment outcome (13) 13
warfarin (13) 13
anticoagulants (12) 12
fibrinolytic agents - adverse effects (12) 12
platelet aggregation inhibitors - pharmacology (12) 12
stroke (12) 12
risk (11) 11
thrombin (11) 11
activation (10) 10
peripheral vascular disease (10) 10
platelets (10) 10
acute myocardial-infarction (9) 9
aged (9) 9
analysis (9) 9
anti-thrombotic agents (9) 9
anticoagulation (9) 9
fibrinolytic agents - administration & dosage (9) 9
fibrinolytic agents - chemistry (9) 9
heparin (9) 9
myocardial-infarction (9) 9
acute coronary syndrome (8) 8
bleeding time (8) 8
blood clot (8) 8
guidelines (8) 8
heart failure (8) 8
medicine, research & experimental (8) 8
rats, wistar (8) 8
surgery (8) 8
thrombosis - etiology (8) 8
administration, oral (7) 7
aged, 80 and over (7) 7
anaesthesiology (7) 7
anti-thrombotic treatment (7) 7
anti-thrombotics (7) 7
atrial fibrillation - drug therapy (7) 7
beta-blockers (7) 7
care and treatment (7) 7
coagulation (7) 7
health aspects (7) 7
myocardial infarction - drug therapy (7) 7
non-cardiac surgery (7) 7
perioperative cardiac management (7) 7
platelet-aggregation (7) 7
practice guidelines as topic (7) 7
prospective studies (7) 7
therapy (7) 7
agents (6) 6
aggregation (6) 6
anti-platelet (6) 6
antiplatelet therapy (6) 6
article (6) 6
atrial fibrillation - complications (6) 6
biochemistry & molecular biology (6) 6
cardiology and cardiovascular medicine (6) 6
chemistry, organic (6) 6
clopidogrel (6) 6
derivatives (6) 6
disease models, animal (6) 6
fibrinolytic agents - chemical synthesis (6) 6
gastroenterology & hepatology (6) 6
hemorrhage - chemically induced (6) 6
inhibition (6) 6
low-dose aspirin (6) 6
management (6) 6
percutaneous coronary intervention (6) 6
rabbits (6) 6
secondary prevention (6) 6
stroke - prevention & control (6) 6
thrombosis - prevention & control (6) 6
anticoagulant (5) 5
anticoagulants - pharmacology (5) 5
arrhythmias (5) 5
arterial thrombosis (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (142) 142
Japanese (14) 14
French (3) 3
Chinese (2) 2
Polish (2) 2
Russian (2) 2
German (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2008, Volume 255, Issue 11, pp. 1679 - 1686
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 6/2006, Volume 8, Issue 4, pp. 428 - 432
Journal Article
Journal of Community Hospital Internal Medicine Perspectives, ISSN 2000-9666, 05/2019, Volume 9, Issue 3, pp. 203 - 210
Background: Long-term oral anticoagulants (OAC) increases bleeding risk after the percutaneous coronary intervention (PCI) with dual antiplatelet therapy... 
triple anti-thrombotic therapy | Oral anticoagulation | atrial fibrillation | bleeding | dual-anti thrombotic therapy
Journal Article
by Kristensen, Steen Dalby and Knuuti, Juhani and Saraste, Antti and Anker, Stefan and Bøtker, Hans Erik and Hert, Stefan De and Ford, Ian and Gonzalez-Juanatey, Jose Ramón and Gorenek, Bulent and Heynickx, Guy Robert and Hoeft, Aneas and Huber, Kurt and Iung, Bernard and Kjeldsen, Keld Per and Longrois, Dan and Lüscher, Thomas F and Pierard, Luc and Pocock, Stuart and Price, Susanna and Roffi, Marco and Sirnes, Per Anton and Sousa-Uva, Miguel and Vouis, Vasilis and Funck-Brentano, Christian and Zamorano, Jose Luis and Achenbach, Stephan and Baumgartner, Helmut and Bax, Jeroen J and Bueno, Héctor and Dean, Veronica and Deaton, Christi and Erol, Cetin and Fagard, Robert and Ferrari, Roberto and Hasdai, David and Hoes, Arno W and Kirchhof, Paulus and Kolh, Philippe and Lancellotti, Patrizio and Linhart, Ales and Nihoyannopoulos, Petros and Piepoli, Massimo F and Ponikowski, Piotr and Tamargo, Juan Luis and Tendera, Michal and Torbicki, Adam and Wijns, William and Windecker, Stephan and Solca, Maurizio and Brichant, Jean-François and Robertis, Edoardo de and Langenecker, Sibylle Kozek and Wichelewski, Josef and Agewall, Stefan and Ceconi, Claudio and Coca, Antonio and Corrà, Ugo and Caterina, Raffaele De and Mario, Carlo Di and Edvardsen, Thor and Germano, Giuseppe and Guarracino, Fabio and Hoes, Arno and Joergensen, Torben and Jüni, Peter and Marques-Vidal, Peo and Mueller, Christian and Oto, Oztekin and Pibarot, Philippe and Sellevold, Olav Fm and Triposkiadis, Filippos and Wouters, Patrick and Authors/Task Force Members
European heart journal, ISSN 0195-668X, 2014, Volume 35, Issue 35, pp. 2383 - 2431
Journal Article
Journal of Cardiovascular Translational Research, ISSN 1937-5387, 10/2014, Volume 7, Issue 7, pp. 644 - 650
Journal Article
Expert Review of Cardiovascular Therapy, ISSN 1477-9072, 03/2011, Volume 9, Issue 3, pp. 253 - 255
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2012, Volume 8, Issue 7, pp. 1216 - 1222
Journal Article
Journal of Arrhythmia, ISSN 1880-4276, 2011, Volume 27, Issue Supplement, pp. SY06_1 - SY06_1
Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with important morbidity and mortality. AF increases the risk of stroke by a... 
stroke | atrial fibrillation | anti-thrombotic therapy
Journal Article
Current Drug Targets, ISSN 1389-4501, 10/2006, Volume 7, Issue 10, pp. 1253 - 1263
Journal Article
Cor et Vasa, ISSN 0010-8650, 2013, Volume 55, Issue 2, pp. e117 - e125
Abstract Despite recent developments in revascularisation, anti-platelet and anti-thrombotic therapies, patients with acute coronary syndromes (ACS) remain at... 
Cardiovascular | Acute coronary syndrome | Anti-thrombotic drugs | Thrombosis | CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
Journal of Arrhythmia, ISSN 1880-4276, 2011, Volume 27
Journal Article
BMC Cardiovascular Disorders, ISSN 1471-2261, 04/2014, Volume 14, Issue 1, pp. 44 - 44
Background: Optimal treatment of acute ST-elevation myocardial infarction (STEMI) involves rapid diagnosis, and transfer to a cardiac centre capable of... 
Antiplatelet therapy | Myocardial infarction | Anti-thrombotic therapy | Percutaneous coronary intervention | Platelet function testing | CARDIAC & CARDIOVASCULAR SYSTEMS | STENT THROMBOSIS | BIVALIRUDIN | CLOPIDOGREL | CLINICAL-TRIALS | PRASUGREL | ELEVATION MYOCARDIAL-INFARCTION | PRIMARY ANGIOPLASTY | Recombinant Proteins - therapeutic use | Myocardial Infarction - blood | Prasugrel Hydrochloride | Predictive Value of Tests | Thiophenes - therapeutic use | Prospective Studies | Thiophenes - adverse effects | Humans | Clinical Protocols | England | Drug Monitoring - methods | Recombinant Proteins - adverse effects | Myocardial Infarction - therapy | Time Factors | Coronary Thrombosis - prevention & control | Platelet Function Tests | Blood Platelets - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Coronary Thrombosis - blood | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Point-of-Care Systems | Blood Platelets - metabolism | Hirudins - adverse effects | Coronary Thrombosis - etiology | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Platelet Activation - drug effects | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Research Design | Transluminal angioplasty | Medicine, Experimental | Medical research | Heart attacks | Drug therapy | Mortality | Index Medicus
Journal Article